Tetramisole hydrochloride

AntiHum CTLA-4,Pure,(clone:A3.4H2.H12,Mse IgG2ak)250ug

AXC-715 (T785) trihydrochloride is a TLR7/TLR8 dual agonist, extracted from patent WO2020168017 A1 AXC-715 trihydrochloride, compound D from WO2020190734A1, can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody

AXC-715 (T785) trihydrochloride is a TLR7/TLR8 dual agonist, extracted from patent WO2020168017 A1 AXC-715 trihydrochloride, compound D from WO2020190734A1, can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody

BMS-1001 hydrochloride is an orally active human PD-L1/PD-1 immune checkpoint inhibitor. BMS-1001 hydrochloride exhibits low-toxicity in cellsIn VitroBMS-1001 binds to human PD-L1 and blocks its interaction with PD-1. BMS-1001 presents low toxicity

BMS-1001 hydrochloride is an orally active human PD-L1/PD-1 immune checkpoint inhibitor. BMS-1001 hydrochloride exhibits low-toxicity in cellsIn VitroBMS-1001 binds to human PD-L1 and blocks its interaction with PD-1. BMS-1001 presents low toxicity

BMS-1001 hydrochloride is an orally active human PD-L1/PD-1 immune checkpoint inhibitor. BMS-1001 hydrochloride exhibits low-toxicity in cellsIn VitroBMS-1001 binds to human PD-L1 and blocks its interaction with PD-1. BMS-1001 presents low toxicity

BMS-1001 hydrochloride is an orally active human PD-L1/PD-1 immune checkpoint inhibitor. BMS-1001 hydrochloride exhibits low-toxicity in cellsIn VitroBMS-1001 binds to human PD-L1 and blocks its interaction with PD-1. BMS-1001 presents low toxicity

BMS-1001 hydrochloride is an orally active human PD-L1/PD-1 immune checkpoint inhibitor. BMS-1001 hydrochloride exhibits low-toxicity in cellsIn VitroBMS-1001 binds to human PD-L1 and blocks its interaction with PD-1. BMS-1001 presents low toxicity

BMS-1001 hydrochloride is an orally active human PD-L1/PD-1 immune checkpoint inhibitor. BMS-1001 hydrochloride exhibits low-toxicity in cellsIn VitroBMS-1001 binds to human PD-L1 and blocks its interaction with PD-1. BMS-1001 presents low toxicity

A potent, specific, and orally active C5a receptor antagonist. Shown to inhibit the binding of 125 I-rhC5a to human neutrophils with a K i of 2.

A potent, specific, and orally active C5a receptor antagonist. Shown to inhibit the binding of 125 I-rhC5a to human neutrophils with a K i of 2.

General description Carbon tetrachloride (CCl 4 ) is a clear, colourless, volatile and very stable chlorinated hydrocarbon. It is widely used as a solvent for fats, varnishes, oils, lacquers, resins, and rubber waxes.